ALVEOLUS BIO

Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. Our pipeline includes preclinical phase live biotherapeutics for Chronic Obstructive Pulmonary Disease (COPD), Lung Injury Secondary to Viral Illness, Bronchopulmonary Dysplasia (BPD), Neutrophilic Asthma, and earlier stage programs, including Pulmonary Arterial Hypertension (PAH), Acute Respiratory Distress Syndrome, and Idiopathic Pulmonary Fibrosis .

Also known as: Alveolus Bio Inc

Primary location: Birmingham United States